Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates

P Ann Boriack-Sjodin1, Lei Jin1, Suzanne L Jacques1

  • 1Epizyme, Inc. 400 Technology Square, Cambridge, Massachusetts 02139, United States.

ACS Chemical Biology
|November 10, 2015
PubMed

Insights

Coactivator-associated arginine methyltransferase 1 (CARM1) enzyme structures reveal how it binds diverse peptide substrates. These findings offer insights into CARM1

Area of Science:

  • Biochemistry
  • Structural Biology
  • Enzymology

Background:

  • Coactivator-associated arginine methyltransferase 1 (CARM1) is a key enzyme in cancer, known to methylate histone H3 and other proteins.
  • Previous studies solved CARM1 structures with inhibitors, but lacked ternary structures detailing substrate interactions.

Purpose of the Study:

  • To elucidate the structural basis of CARM1's substrate recognition and binding.
  • To present the first ternary structures of CARM1 with both a cofactor mimic and diverse peptide substrates.

Main Methods:

  • X-ray crystallography was employed to determine the structures of human CARM1.
  • Structures were solved in complex with sinefungin (an S-adenosylmethionine mimic) and three distinct peptide sequences (from histone H3 and PABP1).

Main Results:

  • The study presents crystal structures of human CARM1 bound to sinefungin and peptides, showcasing both unmethylated and monomethylated arginine residues.
  • This work is the first to solve multiple substrate sequences within a single protein arginine methyltransferase (PRMT) enzyme.
  • The CARM1 binding site demonstrates adaptability to various peptide sequences while maintaining a conserved binding mode for substrates.

Conclusions:

  • The presented structures provide a detailed understanding of how CARM1 accommodates different peptide substrates.
  • Comparative analysis with other PRMT structures reveals potential conserved hydrogen bonding patterns in substrate binding sites.
  • These findings contribute to understanding CARM1's role in biological processes and cancer, potentially guiding future drug design.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.1K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.1K
Carbocations02:10

Carbocations

Carbocations are one of the reaction intermediates formed during several nucleophilic substitutions or elimination reactions. A carbocation is an electron-deficient species with the central carbon atom having six electrons and three bonded atoms. The central carbon in a carbocation is sp2 hybridized with trigonal planar geometry. It has an empty p orbital perpendicular to the plane of the structure that can accept electrons. Thus, carbocations act as strong electrophiles and may react with any...
14.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
6.0K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.4K